Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.
Joining the session is Dr. Collin Hovinga, Senior Vice President of Rare and Orphan Disease Programs at C-Path, underscoring ...
FARMINGTON, Conn. (WTNH) — Researchers, biotech executives and policy makers came together Tuesday morning for a rare disease ...
Hosted by Becky Quick, CNBC will debut an in-depth, one-hour special, “CNBC Cures: Defying Rare Disease,” spotlighting the families dealing with rare diseases and the scientists, advocates, and ...
Human cells have two copies of each chromosome, and this balance is essential for genes to be expressed in the appropriate ...
A chance meeting in a DC hallway turns into a movement SPRINGFIELD, IL, UNITED STATES, March 13, 2026 /EINPresswire.com/ — In the world of rare diseases, finding someone who understands your journey ...
An early look at CNBC's new 1-hour documentary, Defying Rare Disease. Defying Rare Disease offers an inside look at the everyday challenges faced by the rare disease community. It documents the ...
A Phase III trial of Rhythm Pharmaceuticals’ Imcivree (setmelanotide) failed to meet its primary endpoints in four rare, ...
More than 100 marchers took to Capitol Hill on Wednesday, carrying a coffin to the FDA in a symbolic protest highlighting lives they say could be lost to regulatory delays affecting a group of rare ...
Torie Bosch is the First Opinion editor at STAT. Celena Lozano’s son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this ...
There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial ...
"CNBC Cures: Defying Rare Disease" will air on Thursday, March 19 at 7PM ET.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results